Is SLU-PP-332 FDA approved?
No. This profile records SLU-PP-332 as not FDA approved and for research use only.
MORE CONTEXT ›
Review the regulatory and source details on this page for the current context.
THE EXERCISE PILL
Estrogen-Related Receptor Agonist; Exercise Mimetic
SLU-PP-332 is a synthetic compound that mimics some effects of exercise by activating ERR receptors, boosting mitochondrial function, endurance, and fat burning without actually working out.
Not FDA approved · research use only
Reviewed by our clinical team
1 research sources
Aug 28, 2026
Dose and schedule recommendations shown below come from The Peptide App Clinical Team. Research links are provided so readers can inspect the supporting evidence directly. Review the sources.
No. This profile records SLU-PP-332 as not FDA approved and for research use only.
Review the regulatory and source details on this page for the current context.
Dose: 5 mg orally or subcutaneously twice daily (experimental).
Schedule: daily. Cycle: 6 weeks on, 6 weeks off. This is clinical-team guidance for reference and does not replace individualized instructions from a licensed clinician.
This guide links to 1 curated or current research sources.
Open the research section to inspect the source titles, publication details, study types, and available abstracts directly.
Agonizes ERRα/β/γ to mimic exercise signaling
Increases PGC-1α to grow new mitochondria
Enhances fatty acid transport and burning
Increases UCP1/UCP3 for heat production
The live research feed did not return papers for this page. The curated references below remain available for crawlable source context.